Evaluation of a Novel Head-Mounted Device for Glaucoma Testing: A Proof-of-Concept Study
NCT ID: NCT05030714
Last Updated: 2023-02-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
120 participants
INTERVENTIONAL
2023-04-30
2026-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating Home Testing Devices for the Management of Glaucoma
NCT05325996
Feasibility, Accuracy, and Reproducibility of Virtual Reality Visual Field Testing in Patients With Glaucoma
NCT07063537
Clinical Evaluation of Visual Field Change in Glaucoma: an Assessment of Different Models of Progression
NCT05801471
Comparison of Critical Flicker Fusion Versus Automated Visual Fields in the Detection of Early Glaucoma
NCT01076114
Study to Compare Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) in Glaucoma Patients
NCT00902109
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single Arm
Patients will perform visual field testing with the Humphrey Visual Field Analyzer and with the custom head-mounted device.
Visual Field Testing
Visual field testing using the protocol 24-2 and/or 10-2 Threshold Test
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Visual Field Testing
Visual field testing using the protocol 24-2 and/or 10-2 Threshold Test
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to understand and consent to the study.
Exclusion Criteria
* Diagnosis of non-glaucomatous optic neuropathy or other significant ophthalmic diagnosis that could limit vision (ex. age-related macular degeneration)
* Significant media opacity
* Previous intraocular surgery other than cataract surgery
* Anxiety disorder
* Pregnancy
* Seizure disorder
* Cardiac pacemaker or other implantable devices
* Severe vertigo or balance disturbance
* Refractive error greater than +4 diopters and less than -6 diopters spherical equivalent
* Inability to demonstrate competence to make informed decision regarding study participation
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Brennan Eadie
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Brennan Eadie
Assistant Professor, Department of Ophthalmology, Dalhousie University and Nova Scotia Health Authority; MD, PhD, FRCSC
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brennan Eadie, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Nova Scotia Healthy Authority
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Victoria General Hopsital - Nova Scotia Health Authority
Halifax, Nova Scotia, Canada
Eadie Technologies Inc.
Halifax, Nova Scotia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.